Articles related to MEDICARE

Oncology practitioners have a new opportunity to ethically enhance their E/M billing through Medicare’s code G2211, which emphasizes the value of sustained care and complexity in patient management.

The Inflation Reduction Act’s out-of-pocket cap on Medicare Part D spending marks a pivotal shift in healthcare economics, potentially altering prescription drug cost dynamics for millions of enrollees. Physicians should be aware of these changes to better support and inform their patients navigating these new financial landscapes.

Stay abreast of the latest HCPCS updates crucial for oncology practice, including new codes for advanced cancer treatments and essential guidelines for principal illness navigation services, to ensure compliance and optimize reimbursement.

Discover how the Inflation Reduction Act influences pharmaceutical innovation and drug pricing. Learn why delaying drug launches might not be an optimal strategy.

Explore the latest study that reveals the increasing role of nurse practitioners and physician assistants in healthcare delivery, accounting for a quarter of all visits.

The proposed changes to the 2024 MPFS could have far-reaching implications for oncology care; stay informed to understand how these changes may impact your practice and patient outcomes.